Dr. Anson Cheung

St. Paul's Hospital's Dr. Webb and Dr. Cheung comment on COSIRA Study

Neovasc Inc. (TSXV: NVC) today reported that final data from its COSIRA trial assessing the efficacy and safety of the Neovasc ReducerTM, a novel percutaneous device for the treatment of refractory angina, was presented on March 29, 2014 in a Featured Clinical Research Presentation at ACC.14, the American College of Cardiology 63rd Annual Scientific Session & Expo.

Making excellent care for acute heart failure patients a priority through innovation and research

Seven years ago, Andrea Marrie unexpectedly became a heart transplant candidate. Because a donor heart wasn’t available, Dr. Anson Cheung, a cardiovascular surgeon at St. Paul’s Hospital, wasted no time and implanted a left  ventricular assist device (LVAD) in Andrea.

Subscribe to RSS - Dr. Anson Cheung